18F-DOPA PET/MRI for Focal Hyperinsulinism
This study is looking at a special imaging test called 18F-Fluoro Dopa PET/MRI to help find the exact spot in the pancreas causing hyperinsulinism (low blood sugar due to too much insulin). This test uses a small amount of a radioactive tracer (18F-DOPA) to create detailed pictures. The goal is to see how well this imaging can pinpoint the problem area before surgery, especially for patients who haven't responded to medications like diazoxide or octreotide. If you have confirmed hyperinsulinism and your current medications aren't working, you might be able to join this study. The main goal is to make this imaging test more available and to see how accurate it is in guiding treatment.
- Study design
- This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 100 participants.
- What's involved
- Participants will undergo an 18F-Fluoro Dopa PET/MRI imaging study of their pancreas.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study aims to increase access to the imaging for patients with hyperinsulinism who failed medical therapy, measured at one year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Ana Maria Arbelaez, MD, MSCI · PRINCIPAL_INVESTIGATOR · Washington University School of Medicine
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Increase Access to 18F-DOPA PET/MRI (or PET/CT) for patients with HI who failed medical therapyone year
To provide access to 18F-DOPA PET/MRI (or PET/CT) for patients with HI who do not respond to pharmacological therapy and are being considered for pancreatic surgery. We will measure this by totaling the number of scans performed yearly.